Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Kelly, Ronan J, Ajani, Jaffer A, Kuzdzal, Jaroslaw, Zander, Thomas, Van Cutsem, Eric, Piessen, Guillaume, Mendez, Guillermo, Feliciano, Josephine, Motoyama, Satoru, Lièvre, Astrid, Uronis, Hope, Elimova, Elena, Grootscholten, Cecile, Geboes, Karen, Zafar, Syed, Snow, Stephanie, Ko, Andrew H, Feeney, Kynan, Schenker, Michael, Kocon, Piotr, Zhang, Jenny, Zhu, Lili, Lei, Ming, Singh, Prianka, Kondo, Kaoru, Cleary, James M, Moehler, Markus
Published in The New England journal of medicine (01.04.2021)
Published in The New England journal of medicine (01.04.2021)
Get full text
Journal Article
Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
Bang, Yung-Jue, Cho, Jae Yong, Kim, Yeul Hong, Kim, Jin Won, Di Bartolomeo, Maria, Ajani, Jaffer A, Yamaguchi, Kensei, Balogh, Agnes, Sanchez, Teresa, Moehler, Markus
Published in Clinical cancer research (01.10.2017)
Published in Clinical cancer research (01.10.2017)
Get full text
Journal Article
Late-line treatment in metastatic gastric cancer: today and tomorrow
Get full text
Book Review
Journal Article
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Shitara, Kohei, Ajani, Jaffer A, Moehler, Markus, Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Bragagnoli, Arinilda Campos, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Bruges, Ricardo, Zander, Thomas, de Azevedo, Sergio, Kowalyszyn, Ruben, Pazo-Cid, Roberto, Schenker, Michael, Cleary, James M, Yanez, Patricio, Feeney, Kynan, Karamouzis, Michalis V, Poulart, Valerie, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Janjigian, Yelena Y
Published in Nature (London) (31.03.2022)
Published in Nature (London) (31.03.2022)
Get full text
Journal Article
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial
Heinemann, Volker, von Weikersthal, Ludwig Fischer, Decker, Thomas, Kiani, Alexander, Kaiser, Florian, Al-Batran, Salah-Edin, Heintges, Tobias, Lerchenmüller, Christoph, Kahl, Christoph, Seipelt, Gernot, Kullmann, Frank, Moehler, Markus, Scheithauer, Werner, Held, Swantje, Miller-Phillips, Lisa, Modest, Dominik Paul, Jung, Andreas, Kirchner, Thomas, Stintzing, Sebastian
Published in British journal of cancer (02.02.2021)
Published in British journal of cancer (02.02.2021)
Get full text
Journal Article
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Heinemann, Volker, Prof, von Weikersthal, Ludwig Fischer, MD, Decker, Thomas, MD, Kiani, Alexander, Prof, Vehling-Kaiser, Ursula, MD, Al-Batran, Salah-Eddin, Prof, Heintges, Tobias, Prof, Lerchenmüller, Christian, MD, Kahl, Christoph, MD, Seipelt, Gernot, MD, Kullmann, Frank, Prof, Stauch, Martina, MD, Scheithauer, Werner, Prof, Hielscher, Jörg, Scholz, Michael, MD, Müller, Sebastian, MD, Link, Hartmut, Prof, Niederle, Norbert, Prof, Rost, Andreas, MD, Höffkes, Heinz-Gert, Prof, Moehler, Markus, Prof, Lindig, Reinhard U, MD, Modest, Dominik P, MD, Rossius, Lisa, MD, Kirchner, Thomas, Prof, Jung, Andreas, PhD, Stintzing, Sebastian, MD
Published in The lancet oncology (01.09.2014)
Published in The lancet oncology (01.09.2014)
Get full text
Journal Article
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
Stintzing, Sebastian, Dr, Modest, Dominik P, MD, Rossius, Lisa, Lerch, Markus M, Prof, von Weikersthal, Ludwig Fischer, MD, Decker, Thomas, MD, Kiani, Alexander, MD, Vehling-Kaiser, Ursula, MD, Al-Batran, Salah-Eddin, Prof, Heintges, Tobias, MD, Lerchenmüller, Christian, MD, Kahl, Christoph, MD, Seipelt, Gernot, MD, Kullmann, Frank, MD, Stauch, Martina, MD, Scheithauer, Werner, Prof, Held, Swantje, MSc, Giessen-Jung, Clemens, MD, Moehler, Markus, Prof, Jagenburg, Andreas, MD, Kirchner, Thomas, Prof, Jung, Andreas, Prof, Heinemann, Volker, Prof
Published in The lancet oncology (01.10.2016)
Published in The lancet oncology (01.10.2016)
Get full text
Journal Article
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
Michel, Maurice, Kaps, Leonard, Maderer, Annett, Galle, Peter R, Moehler, Markus
Published in Cancers (11.05.2021)
Published in Cancers (11.05.2021)
Get full text
Journal Article
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Lordick, Florian, Prof, Kang, Yoon-Koo, Prof, Chung, Hyun-Cheol, Prof, Salman, Pamela, MD, Oh, Sang Cheul, Prof, Bodoky, György, Prof, Kurteva, Galina, MD, Volovat, Constantin, MD, Moiseyenko, Vladimir M, Prof, Gorbunova, Vera, Prof, Park, Joon Oh, MD, Sawaki, Akira, MD, Celik, Ilhan, Prof, Götte, Heiko, PhD, Melezínková, Helena, MD, Moehler, Markus, Prof
Published in The lancet oncology (01.05.2013)
Published in The lancet oncology (01.05.2013)
Get full text
Journal Article
Molecular landscape of esophageal cancer: implications for early detection and personalized therapy
Talukdar, Fazlur Rahman, di Pietro, Massimiliano, Secrier, Maria, Moehler, Markus, Goepfert, Katrin, Lima, Sheila Soares Coelho, Pinto, Luis Felipe Ribeiro, Hendricks, Denver, Parker, Mohamed Iqbal, Herceg, Zdenko
Published in Annals of the New York Academy of Sciences (01.12.2018)
Published in Annals of the New York Academy of Sciences (01.12.2018)
Get full text
Journal Article
MAHOGANY: margetuximab combination in HER2+ unresectable/metastatic gastric/gastroesophageal junction adenocarcinoma
Catenacci, Daniel Vt, Rosales, Minori, Chung, Hyun Cheol, H Yoon, Harry, Shen, Lin, Moehler, Markus, Kang, Yoon-Koo
Published in Future oncology (London, England) (01.04.2021)
Published in Future oncology (London, England) (01.04.2021)
Get full text
Journal Article
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC
Lim, Ho Yeong, Heo, Jeong, Peguero, Julio A., Ryoo, Baek-Yeol, Decaens, Thomas, Barlesi, Fabrice, Moehler, Markus H., Jehl, Genevieve, Eggleton, S. Peter, Bajars, Marcis, Gulley, James L.
Published in Hepatology (Baltimore, Md.) (13.08.2024)
Published in Hepatology (Baltimore, Md.) (13.08.2024)
Get full text
Journal Article
Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patients
Haupts, Anna, Vogel, Anne, Foersch, Sebastian, Hartmann, Monika, Maderer, Annett, Wachter, Nicolas, Huber, Tobias, Kneist, Werner, Roth, Wilfried, Lang, Hauke, Moehler, Markus, Hartmann, Nils
Published in Scientific reports (18.08.2021)
Published in Scientific reports (18.08.2021)
Get full text
Journal Article
Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives
Taieb, Julien, Moehler, Markus, Boku, Narikazu, Ajani, Jaffer A., Yañez Ruiz, Eduardo, Ryu, Min-Hee, Guenther, Silke, Chand, Vikram, Bang, Yung-Jue
Published in Cancer treatment reviews (01.05.2018)
Published in Cancer treatment reviews (01.05.2018)
Get full text
Journal Article
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Hofheinz, Ralf-Dieter, Prof, Wenz, Frederik, Prof, Post, Stefan, Prof, Matzdorff, Axel, Prof, Laechelt, Stephan, MD, Hartmann, Jörg T, Prof, Müller, Lothar, MD, Link, Hartmut, Prof, Moehler, Markus, Prof, Kettner, Erika, MD, Fritz, Elisabeth, MD, Hieber, Udo, MD, Lindemann, Hans Walter, MD, Grunewald, Martina, MD, Kremers, Stephan, MD, Constantin, Christian, MD, Hipp, Matthias, MD, Hartung, Gernot, Prof, Gencer, Deniz, MD, Kienle, Peter, Prof, Burkholder, Iris, PhD, Hochhaus, Andreas, Prof
Published in The lancet oncology (01.06.2012)
Published in The lancet oncology (01.06.2012)
Get full text
Journal Article
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
Michel, Maurice, Hess, Cornelius, Kaps, Leonard, Kremer, Wolfgang M, Hilscher, Max, Galle, Peter R, Moehler, Markus, Schattenberg, Jörn M, Wörns, Marcus-Alexander, Labenz, Christian, Nagel, Michael
Published in Scientific reports (15.10.2021)
Published in Scientific reports (15.10.2021)
Get full text
Journal Article
PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression
Dörsam, Bastian, Seiwert, Nina, Foersch, Sebastian, Stroh, Svenja, Nagel, Georg, Begaliew, Diana, Diehl, Erika, Kraus, Alexander, McKeague, Maureen, Minneker, Vera, Roukos, Vassilis, Reißig, Sonja, Waisman, Ari, Moehler, Markus, Stier, Anna, Mangerich, Aswin, Dantzer, Françoise, Kaina, Bernd, Fahrer, Jörg
Published in Proceedings of the National Academy of Sciences - PNAS (24.04.2018)
Published in Proceedings of the National Academy of Sciences - PNAS (24.04.2018)
Get full text
Journal Article
VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
Smyth, Elizabeth, Knödler, Maren, Giraut, Anne, Mauer, Murielle, Nilsson, Magnus, Van Grieken, Nicole, Wagner, Anna Dorothea, Moehler, Markus, Lordick, Florian
Published in Frontiers in oncology (30.01.2020)
Published in Frontiers in oncology (30.01.2020)
Get full text
Journal Article